September 29, 2020 09:13 AM EDT
Financing
Deals
R&D

Armed with a PhI can­cer drug from Bay­er, an Ac­er­ta founder breaks cov­er and writes him­self a $60M blank check deal

John Carroll

Editor & Founder

Ahmed Hamdy has been busy.

This morn­ing Hamdy — one of the key co-founders at Ac­er­ta — jumped out of stealth mode with a new biotech that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times